Molina Healthcare, Inc. v. Celgene Corporation

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

MOLINA HEALTHCARE, INC., Case No. 21-cv-05483-JCS Plaintiff,

v. ORDER GRANTING MOTION TO

REMAND

CELGENE CORPORATION, et al., Re: Dkt. No. 14 Defendants. 12 I. INTRODUCTION This is one of many cases filed against Defendant Celgene Corporation and its parent Defendant Bristol-Myers Squibb Company (“BMS”) regarding Celgene’s1 efforts to protect the market for two of its prescription drugs, Thalomid and Revlimid, from generic competitors. After opting out of an earlier class action and having been dismissed from a case in Minnesota, Plaintiff Molina Healthcare, Inc. (“Molina”) brought this action in the California Superior Court for the County of San Francisco,2 asserting claims under the laws of twenty-three states, including California’s Unfair Competition Law (the “UCL”). Defendants removed the case to this Court and move to transfer to the District of New Jersey or dismiss for lack of personal jurisdiction. Molina moves to remand. The Court finds the matter…